Preceptorship Programme

24th May to 26th May 2021

Preceptorship Programme

24th May to 26th May 2021

The Preceptorship Programme is designed to provide training for junior faculty, young doctors, trainers and new specialists with up-to-date clinical guidance. This year, topics covered included Investigations of Abnormal Liver Function Tests,  Overviews of Clinical Manifestations of Liver Cirrhosis and Biliary Diseases.   New techniques and data have significantly changed the way doctors approach and manage many common Liver Conditions and Diseases.

To facilitate interactions, all our Preceptees were each required to submitt a difficult case study on HBV, HCV, NASH, HCC or other liver disease.  Of these, 15 case studies were selected for oral presentations on line and 3 outstanding Preceptee presentations (one for each evening) were awarded first prize.

The Preceptorship Programme is designed to provide training for junior faculty, young doctors, trainers and new specialists with up-to-date clinical guidance. This year, topics covered included Investigations of Abnormal Liver Function Tests,  Overviews of Clinical Manifestations of Liver Cirrhosis and Biliary Diseases.   New techniques and data have significantly changed the way doctors approach and manage many common Liver Conditions and Diseases.

To facilitate interactions, all our Preceptees were each required to submitt a difficult case study on HBV, HCV, NASH, HCC or other liver disease.  Of these, 15 case studies were selected for oral presentations on line and 3 outstanding Preceptee presentations (one for each evening) were awarded first prize.

Please click on "WATCH VIDEO" below to view the videos of the Experts Presentations and the Case Study Presentations.

All Preceptees who attended the Preceptorship Programme will be given favourable consideration to attend the Preceptorship Programme in
2022 when we hope to hold it  LIVE in Singapore
.

Preceptorship Programme 2021 - Top 3 Winners

Dr. Ho Yoke Fun

Gastroenterology and Hepatology
Queen Elizabeth Hospital,
Sabah, Malaysia

Management of Patient with Possible Drug Induced Liver Injury or Drug Induced AIH from Supplement Intake

Dr. Akash Roy

Department of Hepatology
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Management of Diabetic Patient with Jaundice and Ascites

Dr. Van Huy Vo

GI Department
University Medical Center,
HCM City Vietnam

Type B Hepatic-encephalopathy due to congenital portal-systemic shunt

Preceptees selected for oral presentation

This program is being supported by means of an unrestricted educational grant by Gilead Sciences Inc.

What do previous participants say about the Preceptorship Programme?

Benefits

The following benefits are available to Young Doctors who have been accepted for the Preceptorship Programme Online

SHC 2021 Preceptorship Programme

What will you learn?

In this Preceptorship Programme you will learn:

  • The latest updates and training for the clinical management of liver diseases including Chronic Hepatitis B and C, NASH, HCC and other liver diseases
  • The natural history of Hepatitis B and C, NASH and HCC
  • How to interpret clinical data and manage complex liver disease cases.

Eligibility

The applicant must:

  • Have a Medical Degree in their country and be a practicing physician or trainee
  • Be considered a Junior Doctor (below Assistant Professor), Trainee, Recent Specialist or Physician
  • Submit a difficult case study on HBV, HCV, NASH or HCC
  • Junior Doctors must not be resident in Singapore to be eligible to participate in the Preceptorship Programme Online
SHC 2021 Preceptorship Programme

Awards

Preceptees will be given favourable consideration to attend the Preceptorship Programme when held LIVE in Singapore in 2022.

Preceptees whose Case Studies have been selected for oral presentations will be awarded a sum of USD 200.
Preceptees whose Case Studies have been ranked in the top three oral presentations will be awarded a sum of USD 500 each.

SHC 2021 Preceptorship Programme

Awards payments shall only be made on the following terms and conditions:

  1. One person, one application only.
  2. The preceptee’s attendance of at least 80% of the Preceptorship Programme and Online Conference is verified by SHC’s electronic records.
  3. If the young doctor’s case study is accepted for oral presentation, he/she must present his/her case at the online webinar.
  4. Payments will be made using Paypal by 17 July 2021. Preceptees are therefore requested to set up a Paypal account.

Application Procedure

Important Dates

February

8

Preceptorship Programme - Applications Open

May

10

Preceptorship Programme - Applications Close

May

17

Notification of Acceptance & of Oral Presentation

May

24 May - 26 May

Attend Preceptorship Programme

Important Dates

May, 2021

24

Programme
Evidence Based Medicine (EBM) and interpretation of the medical literature
Prof. Seng Gee Lim (Singapore) View Bio
Watch Video
Investigation of abnormal LFTs
Dr. Guan Huei Lee (Singapore) View Bio
Watch Video
Q & A
Case Presentations (1 hour) Faculty: Prof. Seng Gee Lim, Dr Guan Huei Lee

May, 2021

25

Programme
Is Cirrhosis Present? Diagnosis of Cirrhosis, Non-Invasive Markers and When to Biopsy
Dr. Daniel Huang (Singapore) View Bio
Watch Video
Overview of the Clinical Manifestations of Liver Cirrhosis
Dr. Mark Muthiah (Singapore) View Bio
Watch Video
Q & A
Case Presentations (1 hour) Faculty: Dr Daniel Huang, Dr Mark Muthiah

May, 2021

26

Programme
Benign Liver Diseases and How to Diagnose them: Fibrosing Nodular Hyperplasia, Hemangioma, Hepatic Adenomas and Hepatic Cysts
Dr. Prem Thurairajah (Singapore) View Bio
Watch Video
Overview of Biliary Diseases
Dr. Calvin Koh (Singapore) View Bio
Watch Video
Q & A
Case Presentations (1 hour) Faculty: Dr Prem Thurairajah, Dr Calvin Koh

Dr. Calvin Koh

Dr Koh Jianyi, Calvin obtained his medical degree (MBBS) from the National University of Singapore and underwent further medical training at the National University Hospital, Singapore, in the division of gastroenterology and hepatology, completing his Advanced Specialist Training in gastroenterology.

Following completion of specialist training, he was awarded an Academic Medicine Development Award and undertook an advanced endoscopy fellowship under the auspices of the American Society for Gastrointestinal Endoscopy with the Division of Gastroenterology, Hepatology and Nutrition at the University of Florida, USA to further his interest in interventional endoscopy.

Dr Koh is currently a Consultant at the Division of Gastroenterology and Hepatology, as well as an Assistant Professor at NUS Yong Loo Lin School of Medicine. He currently serves as the director of the Endoscopy Centre, at National University Hospital, Singapore, as well as a core faculty member for the gastroenterology training program. He is a fellow of the Royal College of Physicians (London), as well as the American Society of Gastrointestinal Endoscopy.

His clinical and research interests are pancreatobiliary disease, gastric cancer, colon cancer and general gastroenterology/hepatology. Besides gastroscopy and colonoscopy, he also performs endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, endoscopic mucosal resection of polyps, small bowel enteroscopy.

Prof Lim Seng Gee

Qualifications:
MBBS (Hons Monash), FRACP (Aust), FRCP (London), MD (Monash), FAMS (S’pore), Cert Immunology (King’s College)

Biosketch
Prof Lim currently serves as a Senior Consultant at the Division of Gastroenterology and Hepatology in the National University Hospital, Singapore. He is also a Professor in the Yong Loo Lin School of Medicine, National University of Singapore.  

Prof Lim attained his basic medical degree with honours (MBBS Hons) from the University of Monash, Melbourne, Australia. He later pursued a doctorate degree (MD) in Monash and was awarded the FRACP (Australia), FRCP (London), FAMS (Gasteroenterology, Singapore).  

He is considered a master clinician having trained over 40 gastroenterologists and hepatologists, and is regularly referred difficult to treat liver cases. His main clinical work focuses on the treatment of viral hepatitis (esp. B and C), liver disease and liver cancer. 

Prof Lim’s research activities include leadership in Hepatology research, which focuses on improving treatment for chronic hepatitis B and C, pathophysiology of hepatitis B disease, HBV virology, immunological mechanisms of HBeAg seroconversion, and loss of immune tolerance to hepatitis B virus. He also has an interest in pathophysiology and treatment of liver cancer, primary hepatocyte culture, hepatocyte function, drug related liver disease and non-alcoholic fatty liver disease. 

Prof Lim has over 253 publications in peer-reviewed journals with a H-index of 51, and sits on the editorial board of Liver International Hepatology, International, J Viral Hepatitis, Alimentary Pharmacology and Therapeutics, and Lancet Gastroenterology and Hepatology. He has received over S$48 million in research grants.  

Prof Lim also sits on the Advisory Board of Novartis Pharmaceuticals, Idenix Pharmaceuticals, Bristol Myers Squibb Pharmaceuticals and is on the Speaker’s Bureau for GlaxoSmithKline and Schering Plough Pharmaceuticals. Prof Lim has been an invited speaker at AASLD, EASL and APASL in 2013, 2014 and is a regular speaker at numerous International and Regional meetings on liver disease and viral hepatitis. 

Prof Lim is also an Evidence Based Medicine (EBM) Champion, having founded the annual Asia Pacific EBM workshop in 2004 together with Prof Tony Dans from the Philippines which still runs yearly, and actively teaches and contributes to the development of EBM in Singapore.

Prof Lim is Council member, International Coaliltion for Eradication of Hepatitis B Virus (ICE-HBV), AASLD Asia Pacific Regional Council member, Co-chair ICE-HBV treatment subcommittee, and Co-chair combination therapy subcommittee HBV Forum.

Dr Guan Huei Lee

Designations:

  • Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital
  • Senior Consultant, Liver Transplantation, National University Centre for Organ Transplantation, National University Hospital
  • Medical Director, Adult Liver Transplantation Programme, National University Centre for Organ Transplantation, NUH
  • Research Director, Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital

Qualifications:
MBBS (S’pore), MRCP (UK), FRCP Ed (UK), Ph.D. (S’pore)

Specialties:
Medicine, Organ Transplantation

Sub-specialties:
Gastroenterology Hepatology, Liver Transplantation

Special Interests:
Viral hepatitis, Liver failure, Liver transplantation, Liver cirrhosis, Fatty liver disease.

Biosketch
Dr. Guan-Huei Lee graduated from the National University of Singapore (NUS), and completed his advance specialist training in Gastroenterology in 2009. He received further training a clinical fellow at the Institute of Liver Studies, King’s College Hospital, London, focusing on liver intensive care. He received his PhD from NUS in 2014. He was awarded Fellowship of the Royal College of Physicians of Edinburgh in 2015.

Dr. Lee has helped to strengthen the clinical and research capabilities of the Division of Gastroenterology & Hepatology, National University Hospital (NUH), particularly in the management of liver failure and liver transplantation. He is serving dual role as Deputy Head, Division of Gastroenterology & Hepatology, and Medical Director, Adult Liver Transplantation Programme, National University Centre for Organ Transplantation (NUCOT).

Dr. Lee’s research work centers on the application of innovations in technology and biomedical science to the field of Hepatology.  His current work focuses on developing novel targets to achieve functional cure of chronic hepatitis B. His other research interest includes liver failure, liver cancer, fatty liver and chronic hepatitis E. He has published multiple peer-reviewed research articles in such top-tier journals as the Gastroenterology, Gut, and Molecular & Cellular Biology. His research work has been presented at the major meetings of such organisations as the APASL, EASL, ILTS, and AASLD. He is an investigator of several competitive research grants including the Translational & Clinical Research Flagship (TCR) Programme grant, Clinician Scientist-Individual Research Grant (CS-IRG) and was awarded the NMRC Clinician Scientist Award (CSA).

Personal hobbies and interests: Reading, Tennis, Photography, Hiking and Mountain Climbing.

Dr Daniel Huang

Qualifications:
MBBS (S’pore), MMED (Int Med)(S’pore), MRCP (UK)

Biosketch
Dr Daniel Huang graduated from the Yong Loo Lin School of Medicine, National University of Singapore, and did his postgraduate residency training in NUH. He completed his fellowship in Gastroenterology and Hepatology, and was certified by the Specialist Accreditation Board of Singapore.

Dr Huang has a keen interest in liver transplantation, and is a member of the liver transplant team at the National University Hospital, Singapore. He is also proficient in diagnostic and therapeutic endoscopy.

Dr Huang’s research interest is in hepatocellular carcinoma oncogenesis in the setting of NAFLD and hepatitis B, and performs translational and clinical research in these areas.

Area of Interest:

  • Hepatocellular carcinoma
  • Liver transplantation
  • Non-alcoholic fatty liver disease
  • Hepatitis B

Dr Mark Muthiah

Qualifications:
MBBS (S’pore), MRCP (UK), M.Med (Int Med, S’pore).

Biosketch
Dr Mark Muthiah is a Consultant specialising in Gastroenterology and Hepatology at the National University Hospital, Singapore. He graduated from the Yong Loo Lin School of Medicine, National University of Singapore, and did his postgraduate residency training in NUH. He completed his fellowship in Gastroenterology and Hepatology, and was certified by the Specialist Accreditation Board of Singapore in 2016. 

Dr Muthiah has a keen interest in liver transplants, and is a member of the liver transplant team at the National University Hospital, Singapore. He is also skilled in diagnostic and therapeutic endoscopy, and is involved in colon cancer screening and endoscopic mucosal resection (EMR) of colon polyps. 

Dr Muthiah’s research interest is in cellular therapies to reverse liver fibrosis and promote liver regeneration, and is actively involved in basic and translational research on this subject. He is also the principal investigator for ongoing studies in the field of liver cirrhosis and liver transplantation. He has received awards for his research at both regional and international conferences. 

Dr Muthiah is actively involved in medical education for undergraduates, postgraduates, dentistry students, and pharmacy students. He has received numerous teaching awards from NUH, as well as the Outstanding Tutor Award from the Medical Student Society at the Yong Loo Lin School of Medicine. 

Dr Prem H Thurairajah

Qualifications:
MBBS (India), MRCP (UK), PhD (UK)

Biosketch
Dr. Thurairajah graduated from Kasturba Medical College in India in 1997. He subsequently pursued training in Internal Medicine in the United Kingdom which culminated with membership to the Royal College of Physicians (MRCP) in 2002. He trained in Gastroenterology and Hepatology at the West Midlands Deanery, Birmingham, UK and completed two fellowship stints, his first in Transplant Hepatology at the Liver Unit at Queen Elizabeth Hospital in Birmingham and his second in Hepatobiliary endoscopy (ERCP and EUS) at the University College of London (UCL) before obtained his Completion of Certificate in Specialist Training (CCST) in 2011. He completed a period of research leading to a Doctorate in Philosophy (PhD) in the field of Hepatitis C in 2010. He is well published in peer reviewed journals and continues to engage in clinical research.

He worked as a Consultant Transplant Hepatologist at St. James University Hospital, Leeds, UK in 2012 before moving to the Liver Transplant Unit at the University of Kentucky, USA  as an Assistant Professor in Medicine where he served for 2 years. He moved to Singapore in 2014 and worked at Changi General Hospital , where he set up a treatment programme for Chronic Hepatitis C and served as the Director of Hepatology.

This program is being supported by means of an unrestricted educational grant by Gilead Sciences Inc.

Menu